FOLFOXIRI Plus Panitumumab As First-Line Treatment of RAS Wild-Type Metastatic Colorectal Cancer: The Randomized, Open-Label, Phase II VOLFI Study (AIO KRK0109) Among women with occult uterine sarcoma ...

The FDA is discouraging the use of laparoscopic power morcellation for the removal of the uterus or uterine fibroids in women based on a recent analysis of currently available data. Approximately 1 in ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Minimally ...

The risk for occult gynecologic cancer in women who undergo hysterectomy or myomectomy for benign indications is low but not trivial, particularly in women older than 55 years, a new study suggests.

Barbed sutures have emerged as a transformative tool in laparoscopic gynecologic surgery, particularly in procedures such as myomectomy and hysterectomy. Their design, incorporating unidirectional or ...

Please provide your email address to receive an email when new articles are posted on . Reintervention rates were higher for hysteroscopic myomectomy, uterine artery embolization and endometrial ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Among women with ...

AUSTIN, Texas--(BUSINESS WIRE)--Acessa Health Inc., a women’s health innovator advancing uterine-sparing solutions for symptomatic fibroids, announces over 4,000 women treated with laparoscopic ...